Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4886.56 | 1445 / 1445 | 100% | 76.63 | 183 / 183 |
ovary | 100% | 4016.28 | 180 / 180 | 100% | 119.24 | 430 / 430 |
skin | 100% | 5956.89 | 1809 / 1809 | 100% | 60.46 | 472 / 472 |
thymus | 100% | 5469.99 | 653 / 653 | 100% | 65.40 | 605 / 605 |
brain | 100% | 6979.83 | 2641 / 2642 | 100% | 70.62 | 705 / 705 |
uterus | 100% | 4337.96 | 170 / 170 | 100% | 69.09 | 458 / 459 |
intestine | 100% | 4480.83 | 966 / 966 | 100% | 66.55 | 525 / 527 |
kidney | 100% | 5023.46 | 89 / 89 | 99% | 41.57 | 895 / 901 |
prostate | 100% | 5529.77 | 245 / 245 | 99% | 63.19 | 498 / 502 |
pancreas | 100% | 2294.09 | 327 / 328 | 99% | 52.80 | 177 / 178 |
liver | 100% | 2232.88 | 226 / 226 | 99% | 33.42 | 402 / 406 |
lung | 100% | 4506.84 | 577 / 578 | 99% | 62.79 | 1145 / 1155 |
stomach | 100% | 3691.33 | 359 / 359 | 99% | 68.30 | 283 / 286 |
bladder | 100% | 4491.00 | 21 / 21 | 99% | 72.16 | 498 / 504 |
breast | 100% | 4273.90 | 459 / 459 | 98% | 58.11 | 1101 / 1118 |
adrenal gland | 100% | 4457.60 | 258 / 258 | 98% | 44.65 | 226 / 230 |
adipose | 100% | 3743.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 68.67 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 86.33 | 29 / 29 |
spleen | 100% | 5795.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 62.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 76.00 | 1 / 1 |
blood vessel | 100% | 3773.99 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3249.16 | 800 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5071.04 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 3238.23 | 844 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002250 | Biological process | adaptive immune response |
GO_0006974 | Biological process | DNA damage response |
GO_0071108 | Biological process | protein K48-linked deubiquitination |
GO_0006281 | Biological process | DNA repair |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_2000780 | Biological process | negative regulation of double-strand break repair |
GO_0006508 | Biological process | proteolysis |
GO_0016579 | Biological process | protein deubiquitination |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0055105 | Molecular function | ubiquitin-protein transferase inhibitor activity |
GO_0019784 | Molecular function | deNEDDylase activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0043130 | Molecular function | ubiquitin binding |
Gene name | OTUB1 |
Protein name | Ubiquitin thioesterase (EC 3.4.19.12) Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1) ubiquitinyl hydrolase 1 (EC 3.4.19.12) |
Synonyms | OTB1 HSPC263 OTU1 |
Description | FUNCTION: Hydrolase that can specifically remove 'Lys-48'-linked conjugated ubiquitin from proteins and plays an important regulatory role at the level of protein turnover by preventing degradation . Regulator of T-cell anergy, a phenomenon that occurs when T-cells are rendered unresponsive to antigen rechallenge and no longer respond to their cognate antigen . Acts via its interaction with RNF128/GRAIL, a crucial inductor of CD4 T-cell anergy . Isoform 1 destabilizes RNF128, leading to prevent anergy . In contrast, isoform 2 stabilizes RNF128 and promotes anergy . Surprisingly, it regulates RNF128-mediated ubiquitination, but does not deubiquitinate polyubiquitinated RNF128 . Deubiquitinates estrogen receptor alpha (ESR1) . Mediates deubiquitination of 'Lys-48'-linked polyubiquitin chains, but not 'Lys-63'-linked polyubiquitin chains . Not able to cleave di-ubiquitin . Also capable of removing NEDD8 from NEDD8 conjugates, but with a much lower preference compared to 'Lys-48'-linked ubiquitin . .; FUNCTION: Plays a key non-catalytic role in DNA repair regulation by inhibiting activity of RNF168, an E3 ubiquitin-protein ligase that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites . Inhibits RNF168 independently of ubiquitin thioesterase activity by binding and inhibiting UBE2N/UBC13, the E2 partner of RNF168, thereby limiting spreading of 'Lys-63'-linked histone H2A and H2AX marks . Inhibition occurs by binding to free ubiquitin: free ubiquitin acts as an allosteric regulator that increases affinity for UBE2N/UBC13 and disrupts interaction with UBE2V1 . The OTUB1-UBE2N/UBC13-free ubiquitin complex adopts a configuration that mimics a cleaved 'Lys48'-linked di-ubiquitin chain . Acts as a regulator of mTORC1 and mTORC2 complexes . When phosphorylated at Tyr-26, acts as an activator of the mTORC1 complex by mediating deubiquitination of RPTOR via a non-catalytic process: acts by binding and inhibiting the activity of the ubiquitin-conjugating enzyme E2 (UBE2D1/UBCH5A, UBE2W/UBC16 and UBE2N/UBC13), thereby preventing ubiquitination of RPTOR . Can also act as an inhibitor of the mTORC1 and mTORC2 complexes in response to amino acids by mediating non-catalytic deubiquitination of DEPTOR . . |
Accessions | ENST00000538426.6 [Q96FW1-1] F5GYN4 ENST00000535140.1 ENST00000541478.5 ENST00000428192.6 [Q96FW1-1] Q96FW1 ENST00000535715.5 ENST00000543988.1 F5H4F3 ENST00000543004.5 F5H3F0 F5GYJ8 F5H6Q1 |